S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(-0.85%) $83.14
Gas
(-1.16%) $1.619
Gold
(-0.44%) $2 336.80
Silver
(0.78%) $27.47
Platinum
(0.48%) $926.50
USD/EUR
(-0.17%) $0.933
USD/NOK
(-0.16%) $11.01
USD/GBP
(-0.25%) $0.798
USD/RUB
(0.00%) $92.17

Aktualne aktualizacje dla CSL Ltd [CSL.AX]

Giełda: ASX Branża: Pharmaceuticals, Biotechnology & Life Sciences
Ostatnio aktualizowano29 bal. 2024 @ 05:43

0.14% $ 273.67

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 05:43):

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally...

Stats
Dzisiejszy wolumen 107 103
Średni wolumen 725 457
Kapitalizacja rynkowa 132.25B
EPS $0 ( 2024-02-13 )
Last Dividend $1.621 ( 2023-03-09 )
Next Dividend $0 ( N/A )
P/E 34.91
ATR14 $0.100 (0.04%)

Wolumen Korelacja

Długi: 0.37 (neutral)
Krótki: 0.86 (strong)
Signal:(31.783) Same movement expected

CSL Ltd Korelacja

10 Najbardziej pozytywne korelacje
10 Najbardziej negatywne korelacje

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CSL Ltd Korelacja - Waluta/Towar

The country flag 0.85
( strong )
The country flag 0.71
( moderate )
The country flag 0.00
( neutral )
The country flag 0.76
( moderate )
The country flag -0.29
( neutral )
The country flag -0.54
( weak negative )

CSL Ltd Finanse

Annual 2023
Przychody: $19.59B
Zysk brutto: $9.47B (48.33 %)
EPS: $6.92
FY 2023
Przychody: $19.59B
Zysk brutto: $9.47B (48.33 %)
EPS: $6.92
FY 2022
Przychody: $14.47B
Zysk brutto: $7.68B (53.05 %)
EPS: $6.63
FY 2021
Przychody: $10.27B
Zysk brutto: $5.80B (56.49 %)
EPS: $5.22

Financial Reports:

No articles found.

CSL Ltd Dividends

(Q3/22) (Q4/22) (Q1/23) (Q2/23) (Q3/23) (Q4/23) (Q1/24) (Q2/24) (Q3/24) (Q4/24)
$1.758
(N/A)
$0
(N/A)
$1.621
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)
$0
(N/A)

CSL Ltd Dividend Information - Ex Dividend Knight

Dividend Sustainability Score: 10.00 - good (100.00%) | Divividend Growth Potential Score: 7.26 - Increase likely (45.22%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information
First Dividend $0.0167 1994-11-08
Last Dividend $1.621 2023-03-09
Next Dividend $0 N/A
Payout Date 0000-00-00
Next Payout Date N/A
# dividends 59 --
Total Paid Out $28.07 --
Avg. Dividend % Per Year 0.00% --
Score 4.48 --
Div. Sustainability Score 10.00
Div.Growth Potential Score 7.26
Div. Directional Score 9.64 --
Next Divdend (Est)
(2024-06-24)
$0 Estimate 0.00 %
Dividend Stability
0.10 Very Bad
Dividend Score
4.48
Pay Frequency
Semi-Annually
Yearly Payout
Year Amount Yield

Dividend Commentary

The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Furthermore, its high Dividend Growth Potential Score (DGPS) signals potential dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.

Top 10 dividend Companies for ASX

Symbol Title Last dividend Frequency Years Dividend Yearly Dividend Score
OMH.AX Ex Dividend Junior 2023-05-04 Sporadic 0 0.00%
AFG.AX Ex Dividend Junior 2023-09-04 Semi-Annually 0 0.00%
GDG.AX Ex Dividend Junior 2023-09-08 Semi-Annually 0 0.00%
QBE.AX Ex Dividend Knight 2023-08-17 Annually 0 0.00%
BBN.AX Ex Dividend Knight 2023-08-24 Semi-Annually 0 0.00%
JBH.AX Ex Dividend Knight 2023-08-24 Semi-Annually 0 0.00%
SIG.AX Ex Dividend Knight 2023-09-25 Annually 0 0.00%
CIA.AX Ex Dividend Knight 2023-06-13 Semi-Annually 0 0.00%
MMS.AX Ex Dividend Junior 2023-09-07 Annually 0 0.00%
URF.AX No Dividend Player 2023-06-29 Annually 0 0.00%

Dividend Sustainability Score (DSS)

RatioActual ValueWeightNormalized ValueScoreRange
netProfitMarginTTM0.1801.5006.419.61[0 - 0.5]
returnOnAssetsTTM0.06961.2007.689.21[0 - 0.3]
returnOnEquityTTM0.1561.5009.3810.00[0.1 - 1]
payoutRatioTTM0.450-1.0005.50-5.50[0 - 1]
currentRatioTTM2.150.8004.253.40[1 - 3]
quickRatioTTM0.9710.8009.007.20[0.8 - 2.5]
cashRatioTTM0.2161.5009.9110.00[0.2 - 2]
debtRatioTTM0.282-1.5005.30-7.95[0 - 0.6]
interestCoverageTTM6.971.0008.538.53[3 - 30]
operatingCashFlowPerShareTTM8.342.007.2210.00[0 - 30]
freeCashFlowPerShareTTM3.592.008.2110.00[0 - 20]
debtEquityRatioTTM0.612-1.5007.55-10.00[0 - 2.5]
grossProfitMarginTTM0.4841.0005.265.26[0.2 - 0.8]
operatingProfitMarginTTM0.2441.0007.127.12[0.1 - 0.6]
cashFlowToDebtRatioTTM0.2611.0009.669.66[0.2 - 2]
assetTurnoverTTM0.3880.800-0.748-0.599[0.5 - 2]
Total Score12.02

Dividend Growth Score (DGS)

RatioActual ValueWeightNormalized ValueScoreRange
peRatioTTM34.661.0006.600[1 - 100]
returnOnEquityTTM0.1562.509.6010.00[0.1 - 1.5]
freeCashFlowPerShareTTM3.592.008.8010.00[0 - 30]
dividendYielPercentageTTM1.3931.50010.000[0 - 0.4]
operatingCashFlowPerShareTTM8.342.007.2210.00[0 - 30]
payoutRatioTTM0.4501.5005.50-5.50[0 - 1]
pegRatioTTM7.921.50010.000[0.5 - 2]
operatingCashFlowSalesRatioTTM0.1901.0007.750[0.1 - 0.5]
Total Score7.26

CSL Ltd

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. This segment also conducts research on plasma and non-plasma therapies; and receives license and royalty from the commercialization of intellectual property. The CSL Seqirus segment manufactures and distributes non-plasma biotherapeutic products; and develops influenza related products. CSL Limited was founded in 1916 and is headquartered in Parkville, Australia.

O Sygnały na żywo

Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.

Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej